A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.
SHINE acquires Billerica manufacturing facility and established SPECT product portfolio, expanding leadership in nuclear medicine JANESVILLE, Wis., Jan. 2, 2026 /PRNewswire/ -- SHINE announced today ...
The Rotary Club of Kigali Virunga marked its 25th anniversary with a fundraising exercise that targeted placing advanced medical equipment at the center of its long-term vision to support the health ...